Service Quote Request
Please fill out the form below with your detailed inquiry.
shRNA AAV vectors are typically designed to achieve robust and precise gene silencing by leveraging RNA polymerase III (Pol III) promoters such as U6, H1, or 7SK to drive high-level expression of short hairpin RNA (shRNA). These promoters generate short, uncapped, and non-polyadenylated transcripts that efficiently fold into the intended hairpin structure, ensuring optimal processing by the endogenous RNA interference machinery. For convenient tracking of transduction efficiency and tissue specificity, the shRNA cassette is commonly combined with a separate reporter expression module within the same AAV genome. Fluorescent reporters such as GFP or mCherry are placed under the control of an independent RNA polymerase II promoter, which may be constitutively active (e.g., CMV or CAG) for broad expression or tissue-specific (e.g., hSyn for neurons or GFAP for astrocytes) to restrict reporter expression to defined cell populations. This dual-promoter AAV design enables strong, stable shRNA overexpression while simultaneously providing visual confirmation of vector delivery and promoter activity in vitro and in vivo.
RNA polymerase III (Pol III) promoters (typically U6, H1 and 7SK) are the preferred choice for shRNA expression because they produce transcripts that are optimally structured, precisely defined, and efficiently processed by the RNA interference machinery.
I. Pol III promoters generate short, clean RNA transcripts. Unlike RNA polymerase II, Pol III does not add a 5′ cap or a 3′ poly(A) tail. This is critical for shRNA function, as the absence of these modifications allows the shRNA to fold correctly into its hairpin structure, which is required for efficient Dicer processing.
II. Pol III promoters provide highly precise transcription start and termination sites. Transcription typically terminates at a short poly-T sequence, producing uniform shRNA molecules with consistent length. This uniformity improves reproducibility and reduces variability in knockdown efficiency.
III. Pol III-driven expression yields robust and constitutive shRNA levels. Promoters such as U6 and H1 are naturally optimized for small non-coding RNAs, ensuring sufficient intracellular shRNA concentration for effective gene silencing without reliance on post-transcriptional processing signals.
IV. Pol III promoters minimize unintended regulatory effects. Because Pol III transcripts are not subject to alternative splicing or complex post-transcriptional regulation, the expressed shRNA remains functionally intact, leading to predictable and reliable gene knockdown.
| Feature | U6 Promoter | H1 Promoter | 7SK Promoter |
| Origin | Human or Mouse U6 snRNA | Human RNase P RNA | Human 7SK snRNA |
| Promoter Type | Type 3 (External) | Type 3 (External) | Type 3 (External) |
| Relative Strength | Very Strong / High | Moderate | Strong / Very High |
| Transcript Size | ~100–500 bp | Compact (~100 bp) | ~250 bp |
| Initiation Nucleotide | Strictly requires G (Human) or A (Mouse) | Flexible (can use A or G) | Requires G |
| Toxicity Risk | Higher (due to potential over-saturation of RNAi machinery) | Lower (moderate levels are often better tolerated) | Moderate to High |
| Primary Use Case | Standard gene knockdown; CRISPR/Cas9 sgRNA expression | Therapeutic AAVs; where precise or moderate levels are needed | Multiplexing (using different promoters to avoid interference) |